AUBREY MOSS: Open Payments
NPI 1144004185 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$367 in 17 payments from 10 companies in 2025. Trend: 2023 $402 · 2024 $66 · 2025 $367
Food & beverage: $367
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $93 |
| Alkermes, Inc. | 3 | $58 |
| Tris Pharma Inc | 1 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Lundbeck LLC | 1 | $31 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: COBENFY, ARISTADA, REXULTI, Dyanavel XR, CAPLYTA, Auvelity, INVEGA SUSTENNA, VRAYLAR.
Industry payments across TN — which companies pay providers there.
